To further assess whether the reduction of tumor growth upon DOX+GLUT1i is, at least partially, CD8+ T cell-dependent, we performed an analogous experiment in which we depleted CD8+ T cells from Ccne1+ tumor bearing mice before DOX+GLUT1i treatment (Supplementary Fig. 6d). The gene discussed is CD8A; the disease is neoplasm.